30 Nov 2018

Reply

Omalizumab and Dornase alpha formulations needed for the US market [ENA02794]
A leading global pharmaceutical company is looking for manufacturers who can supply or are developing Omalizumab and Dornase alpha formulations for the US market.

Comments :

bd@qbdbiosciences.com

Hi We have access to Omalizumab entering Phase-1 and Dornase in Phase-3 . Other recombinant and biosimlars are also available for US market for licensing. Please share details of your company on my email id.

20:23,  30 Nov 2018

hostrinlifesciences@gmail.com

Hii, we do support for the complete formulation development for the same with 3 lab,pilot & commercial batches.

For further requirements please feel free to contact me.

Best Regards,
Andrew P
CEO & MD,
Hostrin Life Sciences,
www.hostringlobal.com
andrew@hostringlobal.com

21:35,  06 Dec 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty